These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5592537)

  • 21. [Aminoaciduria in patients with progressive muscular dystrophy].
    Yoshino Y; Mozai T
    Rinsho Shinkeigaku; 1972 Apr; 12(4):197-204. PubMed ID: 4674560
    [No Abstract]   [Full Text] [Related]  

  • 22. [Changes of the lipid content of skeletal muscles in progressive muscular dystrophy as a basis for a hypothesis of a primary enzyme defect].
    Kunze D; Olthoff D; Schellnack K
    Acta Biol Med Ger; 1968; 21(5):669-78. PubMed ID: 5739848
    [No Abstract]   [Full Text] [Related]  

  • 23. [Urinary amino acids in progressive muscular dystrophy and amyotonia congenita].
    BAUZA C
    Arch Pediatr Urug; 1959 Dec; 30():749-55. PubMed ID: 13797772
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinico-biochemical aspects of studies in progressive muscular dystrophy].
    Badalan L
    Neurol Neurochir Pol; 1969; 3(3):291-6. PubMed ID: 5803004
    [No Abstract]   [Full Text] [Related]  

  • 25. [Chromatographic study of aminoaciduria in subjects with progressive muscular dystrophy and in healthy carriers of such a defect].
    Brunelli B; Falorni A; Cao A; Lungarotti MS; Tangheroni W
    Pediatria (Napoli); 1971; 79(2):168-80. PubMed ID: 5095771
    [No Abstract]   [Full Text] [Related]  

  • 26. Aminoaciduria in progressive muscular dystrophy.
    AMES SR; RISLEY EA
    Proc Soc Exp Biol Med; 1948 May; 68(1):131-5. PubMed ID: 18863698
    [No Abstract]   [Full Text] [Related]  

  • 27. [Free plasma and erythrocyte amino acids as an index of degree of adaptation to the myodystrophic process in different forms of progressive muscular dystrophy].
    Badalian LO; Dzhutova ED; Temin LA; Kushelev AR
    Lab Delo; 1983; (10):34-7. PubMed ID: 6196530
    [No Abstract]   [Full Text] [Related]  

  • 28. Is nebulin the defective gene product in Duchenne muscular dystrophy?
    Wood DS; Zeviani M; Prelle A; Bonilla E; Salviati G; Miranda AF; DiMauro S; Rowland LP
    N Engl J Med; 1987 Jan; 316(2):107-8. PubMed ID: 3785354
    [No Abstract]   [Full Text] [Related]  

  • 29. Specific increase of taurine in denervated skeletal muscle.
    Iwata H; Baba A
    Prog Clin Biol Res; 1985; 179():397-405. PubMed ID: 4059220
    [No Abstract]   [Full Text] [Related]  

  • 30. [Biochemical research in progressive muscular dystrophy. I. Study of tissue respiration and the free sulfhydryl groups of muscular tissue].
    Duma D; Popoviciu L; Proinov I; Lazăr TC; Cătană R; Serban M; Mareş V; Abrudan M
    Stud Cercet Neurol; 1966; 11(2):99-105. PubMed ID: 5941631
    [No Abstract]   [Full Text] [Related]  

  • 31. [Phosphatides of skeletal musculature in progressive muscular dystrophy--a study on muscle biopsy material].
    Kunze D; Olthoff D; Schellnack K
    Acta Biol Med Ger; 1967; 19(6):1057-9. PubMed ID: 5592035
    [No Abstract]   [Full Text] [Related]  

  • 32. [Symposium on the significance of enzymes in the field of internal medicine. Abnormality of myoglobin subfractions and creatinine kinase isozyme pattern in skeletal muscles of Duchenne type of progressive muscular dystrophy].
    Miyoshi K
    Nihon Naika Gakkai Zasshi; 1965 Oct; 54(7):759-60. PubMed ID: 5894803
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pathogenesis of several forms of progressive muscular dystrophy].
    Lobzin VS; Shapkin VI; Kozlov AV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(3):267-72. PubMed ID: 220822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Determination of free amino acids in the serum and muscles].
    Kłys W; Kunachowicz H; Czarnowska-Misztal E; Wicińska M
    Rocz Panstw Zakl Hig; 1978; 29(3):263-9. PubMed ID: 694346
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies on the free amino acid content of urine from healthy and sick children].
    Stuber A
    Orv Hetil; 1966 Dec; 107(50):2358-61. PubMed ID: 5981950
    [No Abstract]   [Full Text] [Related]  

  • 36. Dysbindin, syncoilin, and beta-synemin mRNA levels in dystrophic muscles.
    Wakayama Y; Matsuzaki Y; Yamashita S; Inoue M; Jimi T; Hara H; Unaki A; Iijima S; Masaki H
    Int J Neurosci; 2010 Feb; 120(2):144-9. PubMed ID: 20199207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Plasma and erythrocyte free amino acids in patients with progressive muscular dystrophy].
    Temin PA; Toguzov RT; Griniu LP; Kushelev AR; Dzhutova ED
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(11):29-33. PubMed ID: 7180300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lipoid changes in progressive muscular dystrophy].
    Schellnack K
    Beitr Orthop Traumatol; 1970 Jan; 17(1):91-5. PubMed ID: 5511214
    [No Abstract]   [Full Text] [Related]  

  • 39. [Carnosine and anserine content of muscles in the course of progressive muscular dystrophy].
    Stepanova NG; Grinio LP
    Vopr Med Khim; 1968; 14(2):210-4. PubMed ID: 5682163
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunocytochemical studies of cathepsin D in human skeletal muscle.
    Whitaker JN; Bertorini TE; Mendell JR
    Ann Neurol; 1983 Feb; 13(2):133-42. PubMed ID: 6338808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.